-
The use of combination evidence-based pharmacologic therapy was associated with lower 6-month mortality in patients with ACS.
-
A once-a-day dose of a valacyclovir reduces the rate of transmission of genital herpes (HSV-2) from an infected partner to an uninfected susceptible partner, according to a new study.
-
Along with chronic kidney disease and metabolic syndrome, physicians must be alert and aggressive with respect to identification of all coronary artery disease risk factors, as well as preventive measures for systemic lupus erythematosus.
-
Rosuvastatin is a new statin whose efficacy was compared to that of atorvastatin in 623 patients with heterozygous familial hypercholesterolemia.
-
In this paper, Grimm and colleagues report on the usefulness of noninvasive testing to predict risk for arrhythmias in patients with idiopathic dilated cardiomyopathy.
-
This study reports the association between inflammation as measured by C-reactive protein and the prevalence and development of atrial fibrillation.
-
-
The first head-to-head comparison study of an ACE inhibitor and an angiotensin receptor blocker, to assess renoprotective effects in type 2 diabetes, has shown that the drugs are comparable in their benefit.
-
Arguably the most important new trial to be reported in New Orleans was the African-American Heart Failure Trial; the use of a combination of isosorbide dinitrate and hydralazine in African-Americans with congestive heart failure.
-
Tissue Doppler echocardiography can distinguish between constrictive pericarditis and restrictive cardiomyopathy.
